Curium in Austria A legacy of excellence in nuclear medicine

In Austria, Curium produce and distribute specialized radiopharmaceuticals to healthcare professionals across Austria and Europe. Our facilities contribute to innovation, quality, and reliable supply to customers and patients across the region.

Dedicated employees

Manufacturing Sites

PET radiopharmaceuticals

100%

Focus on Nuclear Medicine

About Curium in Austria

Curium in Austria was formed in June 2021 through the acquisition of IASON GmbH and ARGOS Zyklotron Betriebs GesmbH.

Local manufacturing expertise
Established in 2021 through the acquisition of IASON GmbH and ARGOS Zyklotron Betriebs GesmbH, Curium in Austria combines specialist PET radiopharmaceutical expertise with the strength of Curium’s global network. With the country head office in Graz and manufacturing facilities in Linz and Klagenfurt, our team of 40 employees is dedicated exclusively to advancing nuclear medicine.

Focused on innovation
Curium in Austria manufactures five PET radiopharmaceuticals that support diagnostic imaging across a range of clinical applications. Through high-quality manufacturing, scientific expertise and a commitment to reliable supply, Curium in Austria helps healthcare professionals deliver earlier diagnoses and improved patient outcomes.

Curium products in Austria

Comprehensive radiopharmaceutical portfolio

Curium in Austria manufactures a portfolio of innovative radiopharmaceutical products supporting diagnostic imaging in nuclear medicine, including Efdege®, PYLCLARI® (Piflufolastat), IASOcholine® (Pcolina®), IASOdopa®, and IASOglio®. Through high-quality manufacturing and scientific expertise, Curium in Austria contributes to reliable patient care and advances in precision diagnostics.

Full portfolio

Product name

Product description

Active ingredient

Disease area

Available in

Country

Product

Product description text

Active ingredient

Ingredient name

Disease area